Exercise testing in metabolic myopathies.
Mark Tarnopolsky
https://pubmed.ncbi.nlm.nih.gov/22239882/Actively Recruiting
Led by Children's Hospital of Philadelphia · Updated on 2025-11-10
90
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are evaluating the effects of conventional exercise and passive exercise through periodic acceleration pGz in individuals with primary mitochondrial disease PMD and healthy volunteers, as well as exploring these effects in patients admitted to a pediatric intensive care unit PICU. This multi-aim study compares responses between PMD patients and healthy controls, and also investigates outcomes in critically ill pediatric patients. Participants in Aim 1 will complete three study visits in random order, each involving a different intervention Cardiopulmonary Exercise Testing CPET, pGz via a bed device, and pGz via a Gentle Jogger device. Aim 2 participants in the PICU will have two study visits during their admission, involving pedal exercise and pGz using the Gentle Jogger. Interventions include exercise testing, passive exercise with devices, and administration of a contrast agent during vascular ultrasound. During study visits, participants will have blood draws before and after interventions, vascular ultrasounds with contrast, and MRI scans of the lower leg. Various measurements such as oxygen consumption, heart rate, plasma lactate levels, and vasodilation will be assessed. The study also includes surveys and scales to evaluate participant responses. Total participation involves multiple visits with detailed monitoring and assessments under medical supervision.
CONDITIONS
Applying pGz in Mitochondrial Disease
K
Katelynn Stanley, BS
D
Daniel McGinn, MSGC
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Children's Hospital of Philadelphia
Lead Sponsor
United States Department of Defense
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Passive Simulated Exercise Devices (pGz Bed, Gentle Jogger, Exercise Pedal) with Vascular Imaging (Lumason® Contrast) | Standard Cardiopulmonary Exercise Testing (CPET) |
|---|---|---|
| What it is | Investigational diagnostic evaluation using passive simulated exercise devices (pGz bed, Gentle Jogger, Exercise Pedal) and vascular imaging with ultrasound contrast (Lumason®) to assess muscle and vascular function in patients with mitochondrial and neuromuscular disorders. | Cardiopulmonary exercise testing (CPET) with a stationary bicycle, considered established practice for evaluating exercise intolerance and maximal aerobic capacity in mitochondrial disease and related myopathies. |
| Role in the study | Tested as novel diagnostic modalities to determine if passive simulated exercise or vascular function measurements can identify mitochondrial dysfunction or abnormalities in neuromuscular disease, including in intensive care settings. | Serves as the reference standard and current established diagnostic test for measuring maximum oxygen consumption and exercise capacity in this population. |
| Primary use | To explore alternative and potentially less physically demanding diagnostic methods to evaluate exercise intolerance, vascular function, and muscle metabolism in people with mitochondrial and neuromuscular diseases. | Used to detect and quantify exercise intolerance and reduced aerobic capacity, which are key diagnostic features of mitochondrial disorders. |
| How it is given or performed | Participants lie down on passive movement devices for about 45 minutes or use the Gentle Jogger while sitting or lying. Muscle and vascular responses are measured using vascular ultrasound after administration of contrast agent (Lumason®). | Participants pedal a stationary bike for approximately 20 minutes, with breathing and heart rate monitored throughout to measure maximal oxygen uptake. |
| Evidence status | Efficacy as a diagnostic tool is under active clinical investigation; no published results for mitochondrial disease diagnostic accuracy are yet available. | Supported by published literature as the validated method for assessing exercise intolerance; diagnostic performance for mitochondrial myopathies is well established. |
| Important limitations | Clinical diagnostic value, specificity, and sensitivity are not yet proven for mitochondrial disease. Reliance on device compliance and technical operator proficiency may limit reproducibility. | Requires participant effort, sufficient mobility, and ability to tolerate exercise; may not be feasible in non-ambulatory, critically ill, or pediatric patients unable to follow instructions. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Participants answer questions about their ability to perform study procedures and physical activity levels.
Duration - 3 separate study visits, each lasting approximately 1 hour per intervention
Participants undergo diagnostic testing including Cardiopulmonary Exercise Testing (CPET), blood draws, vascular ultrasound with Lumason contrast agent, and MRI scans to assess exercise capacity and vascular function.
3 visits with interventions in random order for Aim 1 and healthy controls; 2 visits in fixed order for PICU patients
Duration - Duration depends on participant’s condition and study schedule
Participants are observed for safety and outcomes following the diagnostic evaluations and device interventions.
Follow-up assessments may occur as part of ongoing study visits, but specific visit frequency is not defined
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Mark Tarnopolsky
https://pubmed.ncbi.nlm.nih.gov/22239882/Kim A Sjøberg, Stephen Rattigan, Natalie Hiscock...
https://pubmed.ncbi.nlm.nih.gov/21622816/Catherine DeBrosse, Ravi Prakash Reddy Nanga, Neil Wilson...
https://pubmed.ncbi.nlm.nih.gov/27812541/Feliks Kogan, Mohammad Haris, Catherine Debrosse...
https://pubmed.ncbi.nlm.nih.gov/24925857/Marvin A Sackner, Emerance Gummels, Jose A Adams
https://pubmed.ncbi.nlm.nih.gov/15653959/Jose A Adams, Shivam Patel, Jose R Lopez...
https://pubmed.ncbi.nlm.nih.gov/30402499/J A Adams, M J Mangino, J Bassuk...
https://pubmed.ncbi.nlm.nih.gov/11588467/Arkady Uryash, Jorge Bassuk, Paul Kurlansky...
https://pubmed.ncbi.nlm.nih.gov/25807532/Tanja Taivassalo, Ronald G Haller
https://pubmed.ncbi.nlm.nih.gov/16331135/Danielle S Burstein, Michael G McBride, Jungwon Min...
https://pubmed.ncbi.nlm.nih.gov/32926876/Children's Hospital of Philadelphia
Lead Sponsor
United States Department of Defense
Collaborating Sponsor